From Casetext: Smarter Legal Research

Express Scripts, Inc. v. Horizon Pharma United States, Inc.

SUPERIOR COURT FOR THE STATE OF DELAWARE
Mar 30, 2016
C.A. No. N15C-11-054 MMJ CCLD (Del. Super. Ct. Mar. 30, 2016)

Opinion

C.A. No. N15C-11-054 MMJ CCLD

03-30-2016

EXPRESS SCRIPTS, INC., a Delaware Corporation, Plaintiff, v. HORIZON PHARMA USA, INC., a Delaware Corporation, Defendant.


On Defendant's Written Notice of its Objection to the Continued Sealing of any Pleadings Pursuant to Superior Court Rule 5(g)(4)
GRANTED IN PART, DENIED IN PART ORDER ___Plaintiff has attached Exhibits to its opposition to the notice of objection to continued sealing of pleadings. Exhibit lis the November 9, 2015 Complaint with highlighted redactions that Plaintiff requests remain under seal. Exhibit 2 is the January 11, 2016 Answer and Counterclaim, also with Plaintiff's highlighted redactions.

The Court finds that good cause exists for the following highlighted selections to remain under seal. All other pleadings shall be made available to the public.

EXHIBIT 1 - Complaint of Express Scripts, Inc.:

The highlighted portions of paragraphs 5, 33, 35, 37, 38, 39, 40, 47, 48, 49, 50, 51, and 52.

EXHIBIT 2 - Answer and Counterclaim of horizon Pharma USA, Inc.:

The highlighted portions of paragraphs 5, 33, 35, 37, 38, 39, 40, 47, 48, 49, 50, 51, and 52. The entire Counterclaim shall not be under seal.

IT IS SO ORDERED.

/s/ Mary M. Johnston

The Honorable Mary M. Johnston


Summaries of

Express Scripts, Inc. v. Horizon Pharma United States, Inc.

SUPERIOR COURT FOR THE STATE OF DELAWARE
Mar 30, 2016
C.A. No. N15C-11-054 MMJ CCLD (Del. Super. Ct. Mar. 30, 2016)
Case details for

Express Scripts, Inc. v. Horizon Pharma United States, Inc.

Case Details

Full title:EXPRESS SCRIPTS, INC., a Delaware Corporation, Plaintiff, v. HORIZON…

Court:SUPERIOR COURT FOR THE STATE OF DELAWARE

Date published: Mar 30, 2016

Citations

C.A. No. N15C-11-054 MMJ CCLD (Del. Super. Ct. Mar. 30, 2016)